{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:33:26Z","timestamp":1792481606233,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>People with HIV (PWH) on effective antiretroviral therapy (ART) have an increased risk of developing Non-AIDS Defining Cancers (NADCs) compared to the general population, partly due to chronic inflammation and immune dysregulation. This study aimed to identify plasma biomarkers associated with the risk of developing NADCs in a cohort of PWH on ART.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A case-cohort study was conducted within the Spanish CoRIS cohort, including 316 PWH on ART (71 cases and 245-individuals subcohort). Plasma levels of 24 immune regulation and senescence-associated secretory phenotype (SASP) biomarkers were quantified using Luminex technology. Cox proportional hazards regression models with Borgan II weights were used to assess the association between biomarker levels and the risk of NADC development (hazard ratios), adjusting for confounders. Effect modification by gender was also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Higher baseline plasma levels of twelve biomarkers were significantly associated with increased NADC risk. The strongest associations were found for PD\u2013L2 (aHR=3.33), PAI\u20131 (aHR=2.27), and MMP\u20131 (aHR=2.32). However, a distinct, gender-specific pattern was observed, with significant interactions found for nine biomarkers. Most interactions indicated a higher NADC risk increase in females, with the exception of CD80, TNF\u2013\u03b2 and IP\u201310, which indicated a relatively lower risk in females compared to males.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Plasma biomarkers of immune regulation and SASP are associated with NADC risk in PWH on long-term ART, highlighting the importance of gender-specific pathways in NADC development among PWH. Understanding these distinct profiles may guide future strategies for risk stratification, early detection, and personalized preventive care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1707510","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:06:58Z","timestamp":1761041218000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Immune and senescence profiles associated with non-AIDS-defining cancer risk in people with HIV: a case-cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Carlos","family":"Pita-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Jim\u00e9nez-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martinez-Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Elena G\u00f3mez","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Fari\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pepa","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Roca-Oporto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Mu\u00f1oz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Mart\u00edn-Escolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","year":"2017","journal-title":"Lancet HIV"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw764","article-title":"HIV infection, immunosuppression, and age at diagnosis of non-AIDS-defining cancers","volume":"64","author":"Shiels","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7326\/M17-2499","article-title":"Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030","volume":"168","author":"Shiels","year":"2018","journal-title":"Ann Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-03502-0_9","article-title":"HIV-HBV and HIV-HCV coinfection and liver cancer development","volume":"177","author":"Hu","year":"2019","journal-title":"Cancer Treat Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e328355e131","article-title":"HIV infection, aging, and immune function: implications for cancer risk and prevention","volume":"24","author":"Dubrow","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf248","article-title":"Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort","author":"Han","year":"2025","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/cancers16030546","article-title":"Cancer and HIV: the molecular mechanisms of the deadly duo","volume":"16","author":"Omar","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B8","article-title":"HIV and inflamm-aging: how do we reach the summit of healthy aging","volume":"32","author":"Sheets","year":"2024","journal-title":"Top Antivir Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAI.0000000000001554","article-title":"Inflammation-related morbidity and mortality among HIV-positive adults: how extensive is it","volume":"77","author":"Hart","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2021-001672","article-title":"Sex-based inequalities in contemporary UK hospital management of stable chest pain","volume":"8","author":"Morgan-Hughes","year":"2021","journal-title":"Open Heart"},{"key":"B13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41577-024-00996-9","article-title":"The conneXion between sex and immune responses","volume":"24","author":"Forsyth","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/135965350400900421","article-title":"HIV cohort collaborations: proposal for harmonization of data exchange","volume":"9","author":"Kjaer","year":"2004","journal-title":"Antivir Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2011.06.002","article-title":"The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up","volume":"29","author":"Sobrino-Vegas","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.10.030","article-title":"Bead-based multiplex immuno-assays for cytokines, chemokines, growth factors and other analytes: median fluorescence intensities versus their derived absolute concentration values for statistical analysis","volume":"71","author":"Breen","year":"2015","journal-title":"Cytokine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1023\/A:1009661900674","article-title":"Exposure stratified case-cohort designs","volume":"6","author":"Borgan","year":"2000","journal-title":"Lifetime Data Anal"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2307\/2533444","article-title":"Robust variance estimation for the case-cohort design","volume":"50","author":"Barlow","year":"1994","journal-title":"Biometrics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780090710","article-title":"More powerful procedures for multiple significance testing","volume":"9","author":"Hochberg","year":"1990","journal-title":"Stat Med"},{"key":"B20","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12979-023-00405-0","article-title":"sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence","volume":"21","author":"Aprilia","year":"2024","journal-title":"Immun Ageing"},{"key":"B22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/cells12010106","article-title":"Senescence-associated secretory phenotype of cardiovascular system cells and inflammaging: perspectives of peptide regulation","volume":"12","author":"Khavinson","year":"2022","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.837575","article-title":"Growth differentiation factor-15 in immunity and aging","volume":"3","author":"Pence","year":"2022","journal-title":"Front Aging"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2019-0071OC","article-title":"PAI-1 regulation of TGF-beta1-induced alveolar type II cell senescence, SASP secretion, and SASP-mediated activation of alveolar macrophages","volume":"62","author":"Rana","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1079076","article-title":"Role of CD36 in cancer progression, stemness, and targeting","volume":"10","author":"Guerrero-Rodriguez","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2012.680957","article-title":"Targeting the HGF\/Met signaling pathway in cancer therapy","volume":"16","author":"Cecchi","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2025.01.004","article-title":"Cytokine-driven cancer immune evasion mechanisms","volume":"396","author":"Arenas","year":"2025","journal-title":"Int Rev Cell Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2005.01.004","article-title":"Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis","volume":"16","author":"Presta","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0383-2","article-title":"Sex differences in HIV infection","volume":"15","author":"Scully","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac767","article-title":"Sex differences in subclinical atherosclerosis and systemic immune activation\/inflammation among people with human immunodeficiency virus in the United States","volume":"76","author":"Zanni","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-017-0366-8","article-title":"Sex differences in select non-communicable HIV-associated comorbidities: exploring the role of systemic immune activation\/inflammation","volume":"14","author":"Raghavan","year":"2017","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"155547","DOI":"10.1016\/j.cyto.2021.155547","article-title":"Descriptive modification of inflammatory markers in HIV patients after cART initiation according to gender, smoking habit, CMV infection, BMI and serum lipids","volume":"143","author":"Zanella","year":"2021","journal-title":"Cytokine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2098","article-title":"Choice of time-scale in Cox\u2019s model analysis of epidemiologic cohort data: a simulation study","volume":"23","author":"Thiebaut","year":"2004","journal-title":"Stat Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1707510\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:06:59Z","timestamp":1761041219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1707510\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2025.1707510"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1707510","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"article-number":"1707510"}}